Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR)

Conditions:   ADHD;   Narcolepsy Interventions:   Drug: ADAIR 10 mg IR tablets;   Drug: d-amphetamine sulfate;   Drug: Placebo Sponsor:   Vallon Pharmaceuticals, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials